Tag: metastatic cancer
-
Age Impacts Therapy Outcomes in Metastatic Prostate Cancer
New evidence ties age to outcomes in metastatic prostate cancer A new study published in the October 28, 2025 edition of the New England Journal of Medicine adds an important dimension to how doctors tailor systemic therapy for metastatic prostate cancer. While factors such as tumor biology, disease burden, and prior treatments have long guided…
-
Age Impacts Systemic Therapy in Metastatic Prostate Cancer
New evidence links age to systemic therapy outcomes in metastatic prostate cancer When oncologists assemble a treatment plan for metastatic prostate cancer, they weigh many factors—from tumor genetics to patient comorbidities. A provocative addition to this list is chronological age. A study published in the October 28, 2025 edition of the New England Journal of…
-
Age Shaping Outcomes: How Chronological Age Affects Systemic Therapy in Metastatic Prostate Cancer
New evidence connects age to systemic therapy outcomes in metastatic prostate cancer When doctors assemble a treatment plan for metastatic prostate cancer, they weigh tumor biology, disease burden, patient health, and functional status. A recent study, published in the October 28, 2025 edition of an esteemed medical journal, adds another factor to the decision-making toolkit:…
-
Nanovaccine Shows Promise in Treating HPV-Related Cancers
Breakthrough in HPV-Related Cancer Treatment Scientists at UT Southwestern Medical Center report that a nanoparticle-based vaccine designed to combat cancers caused by the human papillomavirus (HPV) has demonstrated dramatic effects in preclinical studies. The vaccine, built on a nanotechnology platform, target’s HPV-triggered tumors and appears to stimulate the body’s immune system to attack cancer cells…